Newsfeeds - Spark Newswire

1 minute read

Why FibroGen’s Stock Is Getting Hammered Today

Today, 11:02 PM

FibroGen, Inc. (NASDAQ: FGEN) shares are trading lower after an FDA Advisory Committee panel voted against approval of the company's New Drug Application for roxadustat to treat anemia due to chronic kidney disease in adult patients.

FGEN

5 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 11:02 PM

On Friday morning, 68 companies hit new 52-week lows.

ABCL

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For July 16, 2021

By Benzinga Insights

Today, 11:02 PM

1 minute read

GlaxoSmithKline’s Anemia Candidate Shows Promise In Late-Stage Studies

By Vandana Singh

Today, 11:02 PM

GlaxoSmithKline Plc (NYSE:GSK) said its anemia drug for patients with chronic kidney disease succeeded in five late-stage trials. The drug, daprodustat,…

AZN

1 minute read

10 Biggest Price Target Changes For Friday

By Lisa Levin

Today, 11:02 PM

Credit Suisse raised Cintas Corporation (NASDAQ: CTAS) price target from $350 to $375. Cintas shares rose 1.4% to $374.12 in pre-market trading.

COUP

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 11:02 PM

AKBA

3 minute read

22 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 11:02 PM

Gainers Aehr Test Systems (NASDAQ: AEHR) shares rose 25.3% to $3.52 in pre-market trading after the company reported better-than-expected Q4 results and issued strong FY22 sales guidance.

AACG